Gennex Laboratories Ltd.

6.85 +0.13 ▲1.9%

05 June 2023, 01:20:00 PM
Volume: 108,770

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website
Market Cap 119.94 Cr.
Enterprise Value(EV) 122.85 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 0.22 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 30.30 Trailing Twelve Months Ending 2022-12
Industry PE 33.43 Trailing Twelve Months Ending 2022-12
Book Value / Share 2.91 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.30 Calculated using Price: 6.70
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 17.90 Cr. 179,009,534 Shares
FaceValue 1
About Gennex Laboratories Ltd.
Gennex Laboratories (formerly Prudential Pharmaceuticals) is a public limited company established in the year 1995 and has been engaged in the manufacturing of bulk drugs and intermediates. The company started as one of the leading manufacturer and exporter of bulk drugs and intermediates. Quality is the strength of the company and major part of its finished products are exported to various countries viz. Germany, United Kingdom, Spain, Singapore, Canada, Switzerland, Iran, Bangladesh, Pakistan and other major countries. Gennex Laboratories has diversified its activities to biotech products in order to have better prospects and opportunities for the company for expanding its bussiness activities and to meet the marketing requirements.

Gennex Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Gennex Laboratories Ltd. Performance

1 Day
+1.93%
1 Week
+3.47%
1 Month
+7.37%
3 Month
+17.70%
6 Month
+13.41%
1 Year
+5.06%
2 Year
+15.32%
5 Year
+135.40%
10 Year
+696.51%

Gennex Laboratories Ltd. Fundamental Ratios

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 0.82 2.57 8.69 9.14 2.67 6.75 5.32 10.66 9.35
Return on Capital Employed (%) 3.63 4.57 11.78 11.61 6.31 10.49 8.32 13.18 11.78
Return on Assets (%) 0.54 1.66 5.77 5.94 1.68 4.34 3.40 6.95 6.16

Gennex Laboratories Ltd. Balance Sheet

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 25 26 28 31 32 34 36 40 44 46
Non Curr. Liab. 2 1 1 1 1 1 0 0 2
Curr. Liab. 12 13 12 17 18 17 21 19 24 18
Minority Int.
Equity & Liab. 40 39 42 49 50 52 57 59 68 74
Non Curr. Assets 23 22 23 23 23 23 22 23 22 22
Curr. Assets 16 17 19 26 28 29 35 36 47 52
Misc. Exp. not W/O
Total Assets 40 39 42 49 50 52 57 59 68 74

Gennex Laboratories Ltd. Profit and Loss

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 35 32 39 42 44 56 56 60 61 68
Other Income 0 0 0 0 1 1 1 1 1 2
Total Income 35 32 39 42 45 57 57 60 63 70
Total Expenditure -33 -30 -34 -37 -42 -52 -52 -53 -56 -63
PBIDT 2 2 4 5 3 5 4 7 7 7
Interest 0 0 -1 -1 -1 -1 -1 -1 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0 -1 0 -1 -1 -1 -1 -1 -1
Exceptional Items 0 0 0 0
PAT 0 1 2 3 1 2 2 4 4 4
Adjusted EPS 0 0 0 0 0 0 0 0 0 0

Gennex Laboratories Ltd. Cash Flow

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -2 0 0 3 0 3 2 -2 -1 7
Cash Fr. Inv. -1 -1 0 -1 -1 -1 -1 0 0 -1
Cash Fr. Finan. 0 0 0 -2 1 -2 1 0 2 2
Net Change -2 0 0 0 0 0 2 -2 0 7
Cash & Cash Eqvt 0 0 1 1 1 1 3 1 1 8

Gennex Laboratories Ltd. Shareholding Pattern

9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 22.05 22.05 22.05 22.05 22.05 22.05 23.38 23.38 23.38
Public 77.95 77.95 77.95 77.95 77.95 77.95 76.62 76.62 76.62
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 8.07 8.07 8.07 8.84 3.46 3.46

Gennex Laboratories Ltd. Announcements

Thu, 01 Jun 2023
License To Manufacture For Sale(Or For Distribution) Of Drugs Received Deccan Remedies Limited (Subsidiary Company) From Drug Control Administration Of Government Of Andhra Pradesh
We hereby inform you that the Subsidiary of the Company M/s. Deccan Remedies Limited received license to manufacture for sale (or for distribution) of drugsfrom Drug Control Administration of Government of Andhra Pradesh on May 29 2023 licence copy enclosed to this letter. The license shall be valid for a period of 5 Years i.e. 29-05-2023 TO 28-05-2028.list of licence to manufacture for sales (or for distribution) drugs/products List Enclosed :The above said information is intimating Pursuant Reg.30 of SEBI (LODR) Regulations 2015.Request to consider the information on records and oblige the same.
Thu, 01 Jun 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Newspaper Publication on Audited (Standalone & Consolidated) Financial Results for the 4th Quarter and Year Ended March 31 2023 announced by the Board of Directors in its meeting held on Tuesday May 30 2023. Financial results had been published in both Business Standard and Andhra Prabha on Thursday June 01 2023.We request you to take the above information on record and acknowledge receipt of the same.
Thu, 01 Jun 2023
Additional Details Regarding Time Of Commencement And Conclusion Of Board Meeting Of The Company Held On May 30 2023;
This has reference to your email dated 01.06.2023 regarding Additional Details Required for Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations 2015.In continuation to our intimation dated 30.05.2023 with reference to the Outcome of the Board Meeting regarding Audited Standalone and Consolidated Financial Results for the 4th quarter and year ended 31.03.2023 please note that the said Board Meeting had commenced at 16.30 p.m. on 30.05.2023 and concluded at 2.10 a.m. on 31.05.2023.This is for your kind information and records.

Gennex Laboratories Ltd. Technical Scans

Fri, 02 Jun 2023
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 5 Years High Increase in 5 Years
CCI Overbought Zone CCI Overbought Zone
Bullish Harami Cross Bullish Harami Cross

Gennex Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 239,777.54 1,012.85 +1.3%
Divi's Laboratories Ltd. 93,340.08 3,465.00 -1.3%
Cipla Ltd. 77,917.34 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. 76,753.53 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. 71,422.15 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. 60,134.99 1,780.00 +0.1%
Mankind Pharma Ltd. 58,728.27 1,420.60 -3.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.30 1,012.85 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 51.54 3,465.00 -1.3%
Cipla Ltd. Consolidated 2023-03 27.85 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.03 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 87.03 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.23 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 43.99 1,420.60 -3.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.28 1,012.85 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7.36 3,465.00 -1.3%
Cipla Ltd. Consolidated 2023-03 3.33 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.30 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.52 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.65 1,420.60 -3.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,012.85 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,465.00 -1.3%
Cipla Ltd. Consolidated 2022-03 0.04 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,420.60 -3.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,012.85 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,465.00 -1.3%
Cipla Ltd. Consolidated 2022-03 13.10 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,420.60 -3.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,012.85 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,465.00 -1.3%
Cipla Ltd. Consolidated 2022-03 13.10 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,420.60 -3.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,012.85 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,465.00 -1.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,420.60 -3.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,012.85 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,465.00 -1.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,420.60 -3.1%

Gennex Laboratories Ltd. FAQ's

What is Gennex Lab share price?

Can I buy Gennex Lab shares now?

What is the Market Cap of Gennex Lab?

What are the key metrics to analyse Gennex Lab?

What is the 52 Week High and Low of Gennex Lab?

What is the trend of Gennex Lab share price?